APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insomnia Medication

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Insomnia Medication Industry Growth and Trends Forecast to 2032

27 December 2025119 pages

Choose your research edition.

Industry ResearchInsomnia Medication Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Insomnia Medication Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Insomnia Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insomnia Medication Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Insomnia Medication Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Insomnia Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Insomnia Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Insomnia Medication is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insomnia Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Insomnia Medication include Takeda, Eisai, Sanofi, Johnson & Johnson, Merck, Pfizer, Vanda Pharmaceuticals, Somnus Therapeutics and SkyePharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Insomnia Medication market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Insomnia Medication market size, estimates, and forecasts are presented in terms of sales volume (W Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Insomnia Medication market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Insomnia Medication.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Insomnia Medication market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Insomnia Medication Market by Company

Takeda

Eisai

Sanofi

Johnson & Johnson

Merck

Pfizer

Vanda Pharmaceuticals

Somnus Therapeutics

SkyePharma

Purdue Pharma

Pernix Therapeutics

Paratek Pharmaceuticals

Neurim

Minerva Neurosciences

Meda

Flynn Pharma

ECR Pharmaceuticals (Valeant)

Dainippon Sumitomo

Astellas

Insomnia Medication Segment by Type

Benzodiazepine Receptor Agonists

Nonbenzodiazepine Receptor Agonists

The Selective Melatonin Receptor Agonist Ramelteon

Sedating Antidepressants

Insomnia Medication Segment by Application

Adults

Kids

Insomnia Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insomnia Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insomnia Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insomnia Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insomnia Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Insomnia Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Benzodiazepine Receptor Agonists Table 2. Major Company of Nonbenzodiazepine Receptor Agonists Table 3. Major Company of The Selective Melatonin Receptor Agonist Ramelteon Table 4. Major Company of Sedating Antidepressants Table 5. Global Insomnia Medication Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Insomnia Medication Sales by Type (2021-2026) & (W Pcs) Table 7. Global Insomnia Medication Sales Market Share in Volume by Type (2021-2026) Table 8. Global Insomnia Medication Sales by Type (2021-2026) & (US$ Million) Table 9. Global Insomnia Medication Sales Market Share in Value by Type (2021-2026) Table 10. Global Insomnia Medication Price by Type (2021-2026) & (US$/Pcs) Table 11. Global Insomnia Medication Sales by Type (2027-2032) & (W Pcs) Table 12. Global Insomnia Medication Sales Market Share in Volume by Type (2027-2032) Table 13. Global Insomnia Medication Sales by Type (2027-2032) & (US$ Million) Table 14. Global Insomnia Medication Sales Market Share in Value by Type (2027-2032) Table 15. Global Insomnia Medication Price by Type (2027-2032) & (US$/Pcs) Table 16. North America Insomnia Medication Sales by Type (2021-2026) & (W Pcs) Table 17. North America Insomnia Medication Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Insomnia Medication Sales by Type (2021-2026) & (W Pcs) Table 19. Europe Insomnia Medication Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Insomnia Medication Sales by Type (2021-2026) & (W Pcs) Table 21. Asia-Pacific Insomnia Medication Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Insomnia Medication Sales by Type (2021-2026) & (W Pcs) Table 23. Latin America Insomnia Medication Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Insomnia Medication Sales by Type (2021-2026) & (W Pcs) Table 25. Middle East and Africa Insomnia Medication Sales by Type (2021-2026) & (US$ Million) Table 26. Insomnia Medication Industry Trends Table 27. Insomnia Medication Industry Drivers Table 28. Insomnia Medication Industry Opportunities and Challenges Table 29. Insomnia Medication Industry Restraints Table 30. Global Insomnia Medication Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Insomnia Medication Revenue Market Share by Company (2021-2026) Table 32. Global Insomnia Medication Sales by Company (2021-2026) & (W Pcs) Table 33. Global Insomnia Medication Sales Share by Company (2021-2026) Table 34. Global Insomnia Medication Market Price by Company (2021-2026) & (US$/Pcs) Table 35. Global Insomnia Medication Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Insomnia Medication Major Company Production Sites and Headquarters Table 37. Global Insomnia Medication Company, Product Type & Application Table 38. Global Insomnia Medication Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Insomnia Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Insomnia Medication Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Insomnia Medication Sales by Region (2021-2026) & (W Pcs) Table 43. Global Insomnia Medication Sales Market Share in Volume by Region (2021-2026) Table 44. Global Insomnia Medication Sales by Region (2021-2026) & (US$ Million) Table 45. Global Insomnia Medication Sales Market Share in Value by Region (2021-2026) Table 46. Global Insomnia Medication Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 47. Global Insomnia Medication Sales by Region (2027-2032) & (W Pcs) Table 48. Global Insomnia Medication Sales Market Share in Volume by Region (2027-2032) Table 49. Global Insomnia Medication Sales by Region (2027-2032) & (US$ Million) Table 50. Global Insomnia Medication Sales Market Share in Value by Region (2027-2032) Table 51. Global Insomnia Medication Sales (W Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 52. Global Insomnia Medication Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Insomnia Medication Sales by Application (2021-2026) & (W Pcs) Table 54. Global Insomnia Medication Sales Market Share in Volume by Application (2021-2026) Table 55. Global Insomnia Medication Sales by Application (2021-2026) & (US$ Million) Table 56. Global Insomnia Medication Sales Market Share in Value by Application (2021-2026) Table 57. Global Insomnia Medication Price by Application (2021-2026) & (US$/Pcs) Table 58. Global Insomnia Medication Sales by Application (2027-2032) & (W Pcs) Table 59. Global Insomnia Medication Sales Market Share in Volume by Application (2027-2032) Table 60. Global Insomnia Medication Sales by Application (2027-2032) & (US$ Million) Table 61. Global Insomnia Medication Sales Market Share in Value by Application (2027-2032) Table 62. Global Insomnia Medication Price by Application (2027-2032) & (US$/Pcs) Table 63. North America Insomnia Medication Sales by Application (2021-2026) & (W Pcs) Table 64. North America Insomnia Medication Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Insomnia Medication Sales by Application (2021-2026) & (W Pcs) Table 66. Europe Insomnia Medication Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Insomnia Medication Sales by Application (2021-2026) & (W Pcs) Table 68. Asia-Pacific Insomnia Medication Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Insomnia Medication Sales by Application (2021-2026) & (W Pcs) Table 70. Latin America Insomnia Medication Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Insomnia Medication Sales by Application (2021-2026) & (W Pcs) Table 72. Middle East and Africa Insomnia Medication Sales by Application (2021-2026) & (US$ Million) Table 73. Takeda Company Information Table 74. Takeda Business Overview Table 75. Takeda Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 76. Takeda Insomnia Medication Product Portfolio Table 77. Takeda Recent Development Table 78. Eisai Company Information Table 79. Eisai Business Overview Table 80. Eisai Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 81. Eisai Insomnia Medication Product Portfolio Table 82. Eisai Recent Development Table 83. Sanofi Company Information Table 84. Sanofi Business Overview Table 85. Sanofi Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 86. Sanofi Insomnia Medication Product Portfolio Table 87. Sanofi Recent Development Table 88. Johnson & Johnson Company Information Table 89. Johnson & Johnson Business Overview Table 90. Johnson & Johnson Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 91. Johnson & Johnson Insomnia Medication Product Portfolio Table 92. Johnson & Johnson Recent Development Table 93. Merck Company Information Table 94. Merck Business Overview Table 95. Merck Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 96. Merck Insomnia Medication Product Portfolio Table 97. Merck Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 101. Pfizer Insomnia Medication Product Portfolio Table 102. Pfizer Recent Development Table 103. Vanda Pharmaceuticals Company Information Table 104. Vanda Pharmaceuticals Business Overview Table 105. Vanda Pharmaceuticals Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 106. Vanda Pharmaceuticals Insomnia Medication Product Portfolio Table 107. Vanda Pharmaceuticals Recent Development Table 108. Somnus Therapeutics Company Information Table 109. Somnus Therapeutics Business Overview Table 110. Somnus Therapeutics Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 111. Somnus Therapeutics Insomnia Medication Product Portfolio Table 112. Somnus Therapeutics Recent Development Table 113. SkyePharma Company Information Table 114. SkyePharma Business Overview Table 115. SkyePharma Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 116. SkyePharma Insomnia Medication Product Portfolio Table 117. SkyePharma Recent Development Table 118. Purdue Pharma Company Information Table 119. Purdue Pharma Business Overview Table 120. Purdue Pharma Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 121. Purdue Pharma Insomnia Medication Product Portfolio Table 122. Purdue Pharma Recent Development Table 123. Pernix Therapeutics Company Information Table 124. Pernix Therapeutics Business Overview Table 125. Pernix Therapeutics Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 126. Pernix Therapeutics Insomnia Medication Product Portfolio Table 127. Pernix Therapeutics Recent Development Table 128. Paratek Pharmaceuticals Company Information Table 129. Paratek Pharmaceuticals Business Overview Table 130. Paratek Pharmaceuticals Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 131. Paratek Pharmaceuticals Insomnia Medication Product Portfolio Table 132. Paratek Pharmaceuticals Recent Development Table 133. Neurim Company Information Table 134. Neurim Business Overview Table 135. Neurim Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 136. Neurim Insomnia Medication Product Portfolio Table 137. Neurim Recent Development Table 138. Minerva Neurosciences Company Information Table 139. Minerva Neurosciences Business Overview Table 140. Minerva Neurosciences Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 141. Minerva Neurosciences Insomnia Medication Product Portfolio Table 142. Minerva Neurosciences Recent Development Table 143. Meda Company Information Table 144. Meda Business Overview Table 145. Meda Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 146. Meda Insomnia Medication Product Portfolio Table 147. Meda Recent Development Table 148. Flynn Pharma Company Information Table 149. Flynn Pharma Business Overview Table 150. Flynn Pharma Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 151. Flynn Pharma Insomnia Medication Product Portfolio Table 152. Flynn Pharma Recent Development Table 153. ECR Pharmaceuticals (Valeant) Company Information Table 154. ECR Pharmaceuticals (Valeant) Business Overview Table 155. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 156. ECR Pharmaceuticals (Valeant) Insomnia Medication Product Portfolio Table 157. ECR Pharmaceuticals (Valeant) Recent Development Table 158. Dainippon Sumitomo Company Information Table 159. Dainippon Sumitomo Business Overview Table 160. Dainippon Sumitomo Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 161. Dainippon Sumitomo Insomnia Medication Product Portfolio Table 162. Dainippon Sumitomo Recent Development Table 163. Astellas Company Information Table 164. Astellas Business Overview Table 165. Astellas Insomnia Medication Sales (W Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 166. Astellas Insomnia Medication Product Portfolio Table 167. Astellas Recent Development Table 168. North America Insomnia Medication Market Size Growth Rate (CAGR) by Country (W Pcs): 2021 VS 2025 VS 2032 Table 169. North America Insomnia Medication Sales by Country (2021-2026) & (W Pcs) Table 170. North America Insomnia Medication Sales Market Share by Country (2021-2026) Table 171. North America Insomnia Medication Sales Forecast by Country (2027-2032) & (W Pcs) Table 172. North America Insomnia Medication Sales Market Share Forecast by Country (2027-2032) Table 173. North America Insomnia Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. North America Insomnia Medication Market Size by Country (2021-2026) & (US$ Million) Table 175. North America Insomnia Medication Market Share by Country (2021-2026) Table 176. North America Insomnia Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. North America Insomnia Medication Market Share Forecast by Country (2027-2032) Table 178. Europe Insomnia Medication Market Size Growth Rate (CAGR) by Country (W Pcs): 2021 VS 2025 VS 2032 Table 179. Europe Insomnia Medication Sales by Country (2021-2026) & (W Pcs) Table 180. Europe Insomnia Medication Sales Market Share by Country (2021-2026) Table 181. Europe Insomnia Medication Sales Forecast by Country (2027-2032) & (W Pcs) Table 182. Europe Insomnia Medication Sales Market Share Forecast by Country (2027-2032) Table 183. Europe Insomnia Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Europe Insomnia Medication Market Size by Country (2021-2026) & (US$ Million) Table 185. Europe Insomnia Medication Market Share by Country (2021-2026) Table 186. Europe Insomnia Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Europe Insomnia Medication Market Share Forecast by Country (2027-2032) Table 188. Asia-Pacific Insomnia Medication Market Size Growth Rate (CAGR) by Country (W Pcs): 2021 VS 2025 VS 2032 Table 189. Asia-Pacific Insomnia Medication Sales by Country (2021-2026) & (W Pcs) Table 190. Asia-Pacific Insomnia Medication Sales Market Share by Country (2021-2026) Table 191. Asia-Pacific Insomnia Medication Sales Forecast by Country (2027-2032) & (W Pcs) Table 192. Asia-Pacific Insomnia Medication Sales Market Share Forecast by Country (2027-2032) Table 193. Asia-Pacific Insomnia Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Asia-Pacific Insomnia Medication Market Size by Country (2021-2026) & (US$ Million) Table 195. Asia-Pacific Insomnia Medication Market Share by Country (2021-2026) Table 196. Asia-Pacific Insomnia Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Asia-Pacific Insomnia Medication Market Share Forecast by Country (2027-2032) Table 198. Latin America Insomnia Medication Market Size Growth Rate (CAGR) by Country (W Pcs): 2021 VS 2025 VS 2032 Table 199. Latin America Insomnia Medication Sales by Country (2021-2026) & (W Pcs) Table 200. Latin America Insomnia Medication Sales Market Share by Country (2021-2026) Table 201. Latin America Insomnia Medication Sales Forecast by Country (2027-2032) & (W Pcs) Table 202. Latin America Insomnia Medication Sales Market Share Forecast by Country (2027-2032) Table 203. Latin America Insomnia Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. Latin America Insomnia Medication Market Size by Country (2021-2026) & (US$ Million) Table 205. Latin America Insomnia Medication Market Share by Country (2021-2026) Table 206. Latin America Insomnia Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. Latin America Insomnia Medication Market Share Forecast by Country (2027-2032) Table 208. Middle East and Africa Insomnia Medication Market Size Growth Rate (CAGR) by Country (W Pcs): 2021 VS 2025 VS 2032 Table 209. Middle East and Africa Insomnia Medication Sales by Country (2021-2026) & (W Pcs) Table 210. Middle East and Africa Insomnia Medication Sales Market Share by Country (2021-2026) Table 211. Middle East and Africa Insomnia Medication Sales Forecast by Country (2027-2032) & (W Pcs) Table 212. Middle East and Africa Insomnia Medication Sales Market Share Forecast by Country (2027-2032) Table 213. Middle East and Africa Insomnia Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 214. Middle East and Africa Insomnia Medication Market Size by Country (2021-2026) & (US$ Million) Table 215. Middle East and Africa Insomnia Medication Market Share by Country (2021-2026) Table 216. Middle East and Africa Insomnia Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 217. Middle East and Africa Insomnia Medication Market Share Forecast by Country (2027-2032) Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. Insomnia Medication Distributors List Table 221. Insomnia Medication Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. Insomnia Medication Image Figure 2. Global Insomnia Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insomnia Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Insomnia Medication Sales (2021-2032) & (W Pcs) Figure 5. Benzodiazepine Receptor Agonists Image Figure 6. Global Benzodiazepine Receptor Agonists Sales YoY Growth (2021-2032) & (W Pcs) Figure 7. Nonbenzodiazepine Receptor Agonists Image Figure 8. Global Nonbenzodiazepine Receptor Agonists Sales YoY Growth (2021-2032) & (W Pcs) Figure 9. The Selective Melatonin Receptor Agonist Ramelteon Image Figure 10. Global The Selective Melatonin Receptor Agonist Ramelteon Sales YoY Growth (2021-2032) & (W Pcs) Figure 11. Sedating Antidepressants Image Figure 12. Global Sedating Antidepressants Sales YoY Growth (2021-2032) & (W Pcs) Figure 13. Global Insomnia Medication Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Insomnia Medication Market Share by Type 2025 VS 2032 Figure 15. North America Insomnia Medication Sales Market Share in Volume by Type in 2025 Figure 16. North America Insomnia Medication Sales Market Share in Value by Type in 2025 Figure 17. Europe Insomnia Medication Sales Market Share in Volume by Type in 2025 Figure 18. Europe Insomnia Medication Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Insomnia Medication Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Insomnia Medication Sales Market Share in Value by Type in 2025 Figure 21. Latin America Insomnia Medication Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Insomnia Medication Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Insomnia Medication Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Insomnia Medication Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Insomnia Medication Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Adults Image Figure 28. Global Adults Sales YoY Growth (2021-2032) & (W Pcs) Figure 29. Kids Image Figure 30. Global Kids Sales YoY Growth (2021-2032) & (W Pcs) Figure 31. Global Insomnia Medication Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Insomnia Medication Market Share by Application 2025 VS 2032 Figure 33. North America Insomnia Medication Sales Market Share in Volume by Application in 2025 Figure 34. North America Insomnia Medication Sales Market Share in Value by Application in 2025 Figure 35. Europe Insomnia Medication Sales Market Share in Volume by Application in 2025 Figure 36. Europe Insomnia Medication Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Insomnia Medication Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Insomnia Medication Sales Market Share in Value by Application in 2025 Figure 39. Latin America Insomnia Medication Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Insomnia Medication Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Insomnia Medication Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Insomnia Medication Sales Market Share in Value by Application in 2025 Figure 43. North America Insomnia Medication Sales by Country: 2021 VS 2025 VS 2032 (W Pcs) Figure 44. North America Insomnia Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Insomnia Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Insomnia Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Insomnia Medication Sales by Country: 2021 VS 2025 VS 2032 (W Pcs) Figure 48. Europe Insomnia Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Insomnia Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Insomnia Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Insomnia Medication Sales by Country: 2021 VS 2025 VS 2032 (W Pcs) Figure 52. Asia-Pacific Insomnia Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Insomnia Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Insomnia Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Insomnia Medication Sales by Country: 2021 VS 2025 VS 2032 (W Pcs) Figure 56. Latin America Insomnia Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Insomnia Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Insomnia Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Insomnia Medication Sales by Country: 2021 VS 2025 VS 2032 (W Pcs) Figure 60. Middle East and Africa Insomnia Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Insomnia Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Insomnia Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Insomnia Medication Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Insomnia Medication Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Benzodiazepine Receptor Agonists
  • Nonbenzodiazepine Receptor Agonists
  • The Selective Melatonin Receptor Agonist Ramelteon
  • Sedating Antidepressants
Applications
  • Adults
  • Kids
Companies covered
  • Takeda
  • Eisai
  • Sanofi
  • Johnson & Johnson
  • Merck
  • Pfizer
  • Vanda Pharmaceuticals
  • Somnus Therapeutics
  • SkyePharma
  • Purdue Pharma
  • Pernix Therapeutics
  • Paratek Pharmaceuticals
  • Neurim
  • Minerva Neurosciences
  • Meda
  • Flynn Pharma
  • ECR Pharmaceuticals (Valeant)
  • Dainippon Sumitomo
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insomnia Medication Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Insomnia Medication Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Insomnia Medication Market by Type
  6. 1.3.1 Benzodiazepine Receptor Agonists
  7. 1.3.2 Nonbenzodiazepine Receptor Agonists
  8. 1.3.3 The Selective Melatonin Receptor Agonist Ramelteon
  9. 1.3.4 Sedating Antidepressants
  10. 1.4 Global Insomnia Medication Market Size by Type
  11. 1.4.1 Global Insomnia Medication Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Insomnia Medication Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Insomnia Medication Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Insomnia Medication Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Insomnia Medication Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Insomnia Medication Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Insomnia Medication Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Insomnia Medication Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Insomnia Medication Industry Trends
  2. 2.2 Insomnia Medication Industry Drivers
  3. 2.3 Insomnia Medication Industry Opportunities and Challenges
  4. 2.4 Insomnia Medication Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Insomnia Medication Revenue (2021-2026)
  2. 3.2 Global Top Players by Insomnia Medication Sales (2021-2026)
  3. 3.3 Global Top Players by Insomnia Medication Price (2021-2026)
  4. 3.4 Global Insomnia Medication Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insomnia Medication Major Company Production Sites & Headquarters
  6. 3.6 Global Insomnia Medication Company, Product Type & Application
  7. 3.7 Global Insomnia Medication Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insomnia Medication Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insomnia Medication Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insomnia Medication Tier 1, Tier 2, and Tier 3
4 Insomnia Medication Regional Status and Outlook
  1. 4.1 Global Insomnia Medication Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Insomnia Medication Historic Market Size by Region
  3. 4.2.1 Global Insomnia Medication Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Insomnia Medication Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Insomnia Medication Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Insomnia Medication Forecasted Market Size by Region
  7. 4.3.1 Global Insomnia Medication Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Insomnia Medication Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Insomnia Medication Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Insomnia Medication by Application
  1. 5.1 Insomnia Medication Market by Application
  2. 5.1.1 Adults
  3. 5.1.2 Kids
  4. 5.2 Global Insomnia Medication Market Size by Application
  5. 5.2.1 Global Insomnia Medication Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Insomnia Medication Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Insomnia Medication Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Insomnia Medication Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Insomnia Medication Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Insomnia Medication Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Insomnia Medication Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Insomnia Medication Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Insomnia Medication Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Eisai
  8. 6.2.1 Eisai Company Information
  9. 6.2.2 Eisai Business Overview
  10. 6.2.3 Eisai Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Eisai Insomnia Medication Product Portfolio
  12. 6.2.5 Eisai Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Insomnia Medication Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson Insomnia Medication Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Insomnia Medication Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Insomnia Medication Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 Vanda Pharmaceuticals
  38. 6.7.1 Vanda Pharmaceuticals Company Information
  39. 6.7.2 Vanda Pharmaceuticals Business Overview
  40. 6.7.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Vanda Pharmaceuticals Insomnia Medication Product Portfolio
  42. 6.7.5 Vanda Pharmaceuticals Recent Developments
  43. 6.8 Somnus Therapeutics
  44. 6.8.1 Somnus Therapeutics Company Information
  45. 6.8.2 Somnus Therapeutics Business Overview
  46. 6.8.3 Somnus Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Somnus Therapeutics Insomnia Medication Product Portfolio
  48. 6.8.5 Somnus Therapeutics Recent Developments
  49. 6.9 SkyePharma
  50. 6.9.1 SkyePharma Company Information
  51. 6.9.2 SkyePharma Business Overview
  52. 6.9.3 SkyePharma Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 SkyePharma Insomnia Medication Product Portfolio
  54. 6.9.5 SkyePharma Recent Developments
  55. 6.10 Purdue Pharma
  56. 6.10.1 Purdue Pharma Company Information
  57. 6.10.2 Purdue Pharma Business Overview
  58. 6.10.3 Purdue Pharma Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Purdue Pharma Insomnia Medication Product Portfolio
  60. 6.10.5 Purdue Pharma Recent Developments
  61. 6.11 Pernix Therapeutics
  62. 6.11.1 Pernix Therapeutics Company Information
  63. 6.11.2 Pernix Therapeutics Business Overview
  64. 6.11.3 Pernix Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pernix Therapeutics Insomnia Medication Product Portfolio
  66. 6.11.5 Pernix Therapeutics Recent Developments
  67. 6.12 Paratek Pharmaceuticals
  68. 6.12.1 Paratek Pharmaceuticals Company Information
  69. 6.12.2 Paratek Pharmaceuticals Business Overview
  70. 6.12.3 Paratek Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Paratek Pharmaceuticals Insomnia Medication Product Portfolio
  72. 6.12.5 Paratek Pharmaceuticals Recent Developments
  73. 6.13 Neurim
  74. 6.13.1 Neurim Company Information
  75. 6.13.2 Neurim Business Overview
  76. 6.13.3 Neurim Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Neurim Insomnia Medication Product Portfolio
  78. 6.13.5 Neurim Recent Developments
  79. 6.14 Minerva Neurosciences
  80. 6.14.1 Minerva Neurosciences Company Information
  81. 6.14.2 Minerva Neurosciences Business Overview
  82. 6.14.3 Minerva Neurosciences Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Minerva Neurosciences Insomnia Medication Product Portfolio
  84. 6.14.5 Minerva Neurosciences Recent Developments
  85. 6.15 Meda
  86. 6.15.1 Meda Company Information
  87. 6.15.2 Meda Business Overview
  88. 6.15.3 Meda Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Meda Insomnia Medication Product Portfolio
  90. 6.15.5 Meda Recent Developments
  91. 6.16 Flynn Pharma
  92. 6.16.1 Flynn Pharma Company Information
  93. 6.16.2 Flynn Pharma Business Overview
  94. 6.16.3 Flynn Pharma Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Flynn Pharma Insomnia Medication Product Portfolio
  96. 6.16.5 Flynn Pharma Recent Developments
  97. 6.17 ECR Pharmaceuticals (Valeant)
  98. 6.17.1 ECR Pharmaceuticals (Valeant) Company Information
  99. 6.17.2 ECR Pharmaceuticals (Valeant) Business Overview
  100. 6.17.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Portfolio
  102. 6.17.5 ECR Pharmaceuticals (Valeant) Recent Developments
  103. 6.18 Dainippon Sumitomo
  104. 6.18.1 Dainippon Sumitomo Company Information
  105. 6.18.2 Dainippon Sumitomo Business Overview
  106. 6.18.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Dainippon Sumitomo Insomnia Medication Product Portfolio
  108. 6.18.5 Dainippon Sumitomo Recent Developments
  109. 6.19 Astellas
  110. 6.19.1 Astellas Company Information
  111. 6.19.2 Astellas Business Overview
  112. 6.19.3 Astellas Insomnia Medication Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Astellas Insomnia Medication Product Portfolio
  114. 6.19.5 Astellas Recent Developments
7 North America by Country
  1. 7.1 North America Insomnia Medication Sales by Country
  2. 7.1.1 North America Insomnia Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Insomnia Medication Sales by Country (2021-2026)
  4. 7.1.3 North America Insomnia Medication Sales Forecast by Country (2027-2032)
  5. 7.2 North America Insomnia Medication Market Size by Country
  6. 7.2.1 North America Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Insomnia Medication Market Size by Country (2021-2026)
  8. 7.2.3 North America Insomnia Medication Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Insomnia Medication Sales by Country
  2. 8.1.1 Europe Insomnia Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Insomnia Medication Sales by Country (2021-2026)
  4. 8.1.3 Europe Insomnia Medication Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Insomnia Medication Market Size by Country
  6. 8.2.1 Europe Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Insomnia Medication Market Size by Country (2021-2026)
  8. 8.2.3 Europe Insomnia Medication Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Insomnia Medication Sales by Country
  2. 9.1.1 Asia-Pacific Insomnia Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Insomnia Medication Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Insomnia Medication Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Insomnia Medication Market Size by Country
  6. 9.2.1 Asia-Pacific Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Insomnia Medication Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Insomnia Medication Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Insomnia Medication Sales by Country
  2. 10.1.1 South America Insomnia Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Insomnia Medication Sales by Country (2021-2026)
  4. 10.1.3 South America Insomnia Medication Sales Forecast by Country (2027-2032)
  5. 10.2 South America Insomnia Medication Market Size by Country
  6. 10.2.1 South America Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Insomnia Medication Market Size by Country (2021-2026)
  8. 10.2.3 South America Insomnia Medication Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Insomnia Medication Sales by Country
  2. 11.1.1 Middle East and Africa Insomnia Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Insomnia Medication Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Insomnia Medication Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Insomnia Medication Market Size by Country
  6. 11.2.1 Middle East and Africa Insomnia Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Insomnia Medication Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Insomnia Medication Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Insomnia Medication Value Chain Analysis
  2. 12.1.1 Insomnia Medication Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Insomnia Medication Production Mode & Process
  7. 12.2 Insomnia Medication Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Insomnia Medication Distributors
  10. 12.2.3 Insomnia Medication Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst